Total Technology for Drug Supply Management and clinical trial execution
 
Who we are ISS.png
 

Adam Warren, Chief Executive Officer

With over 20 years of diverse pharmaceutical experience, Adam has developed an extensive history of defining and implementing advanced courses of action that optimize the operational complexities and cost efficiencies of global supply chain management.

In 2010, he founded Innovative Supply Solutions (ISS) to provide a full range of clinical drug supply services to clients around the world. ISS has developed a powerful, robust and accurate software platform capable of successfully refining drug supply management. This Total Technology platform leverages real-time visibility to see, control and react to every possible clinical trial variable. It seamlessly integrates each piece of the clinical supply chain at all phases and levels of complexity, allowing users to make rapid adjustments and maximize ROI.

Adam's extensive experience in supply chain management has given him an in-depth understanding of global regulatory compliance, as well as manufacturing, packaging and labeling, distribution and logistics. His career began at the R.W. Johnson Pharmaceutical Research Institute, followed by Ortho-McNeil, Astra Pharmaceuticals (Astra Merck) and AstraZeneca Pharmaceuticals. Prior to founding ISS, Adam spent five years at Johnson and Johnson Pharmaceutical Research and Development as Director of Customer Relationship Management in the Global Clinical Supplies Unit, where he led a seasoned team throughout the United States and Europe. While there, Adam put into practice a CRM model for enhanced operational productivity that generated cost efficiencies in the multi-million dollar range. He also served on the Senior Management team of the CSU and the U.S. ChemPharm Site Leadership Team.

Adam graduated from Penn State University with a bachelor's degree in Biology. He continued his studies at the Philadelphia College of Osteopathic Medicine where he earned a master's degree in Organizational Development and Leadership.

 
ISS Total Technology Clinical Drug Supply Software.jpg

BOARD MEMBERS

Rick Rasansky

Rick is a recognized start-up entrepreneur, investor, and thought leader who leverages social, mobile, analytics and cloud technologies to solve large-scale challenges, drawing on extensive operational expertise in unique identification systems, real-time data services, artificial intelligence, machine learning, and blockchain technologies. He has served as founder, c-level officer and a principal partner of public and private entities spanning technology, venture capital, real estate, aviation, healthcare, hospitality, financial and consumer services. Currently, Rick is the founder and chairman of yorn.com, a customer feedback management platform, and the executive vice president of smart products platform EVRYTHNG.COM, recently named a 2018 World Economic Forum Technology Pioneer.

Mike Cohen

Mike is a global leader in the field of global clinical trial supply, having worked with several of the largest pharmaceutical companies in the world. As the CEO of Myoderm, he's a specialist in sourcing, management, and labeling of commercial drugs and supplies. Before Myoderm, Mike served in executive positions in the publishing, advertising, financial, and utility industries.